As the world marshalled its resources in 2020 to fight the COVID-19 virus pandemic, major pharmaceutical companies were among those on the front lines, racing to develop, test and produce vaccines that could help protect billions of people. Technology played a key role in that effort, not only in creating new vaccines in record time but in ensuring they would be of the highest quality. Johnson & Johnson challenged its pharmaceutical arm, Janssen, with producing one billion doses of its vaccine. To reach that goal, Janssen turned to a contract manufacturer that specialized in rapid manufacturing of vaccines and other treatments in large quantities during public health emergencies.
Veranese Promoted to CEO of AMI
With the continued growth and evolution of Advanced Manufacturing International, Inc. (AMI), the